Results 171 to 180 of about 1,239,680 (224)
Acute Myeloid Leukemia with Core-Binding Factor Rearrangements: A 10-Year Cancer Center Experience.
OncologyFareed S, Soliman DS, Al-Mashdali AF, Gameil A, Mulikandathil Y, Alshurafa A, Abdalla E, Fadul A, Aldali S, Mudawi D, Singh K, Ibrahim F, Hamad A, Cherif H, Yassin M. +14 moreeuropepmc +1 more sourceIntratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical Trial.
JAMA Otolaryngol Head Neck SurgLe Tourneau C, Liem X, Nguyen F, Deraedt S, Salas S, Calugaru V, Serrahima MP, Wong Hee Kam S, Hoffmann C, Lesnik M, Blanchard P, Poissonnet G, Bozec A, Saada-Bouzid E, Jégoux F, Castelli J, Devisetty K, Lelonge Y, Jadaud E, Houdas L, Debard A, Vivar OI, Finzi L, Serra A, Linares I, Arranz Obispo C, Thariat J, Rambeau A, Fakhry N, Santini L, Giralt J, Braña García I, Barba MS, Gorphe P, Helfferich F, Herczeg A, Papai Z, Fijuth J, Takácsi-Nagy Z. +38 moreeuropepmc +1 more sourceWhite blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years. [PDF]
Am J HematolOzga M, Nicolet D, Mrózek K, Walker CJ, Blachly JS, Kohlschmidt J, Orwick S, Carroll AJ, Larson RA, Kolitz JE, Powell BL, Stone RM, Byrd JC, Eisfeld AK, Mims AS. +14 moreeuropepmc +1 more sourceSome of the next articles are maybe not open access.Related searches: